Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan
Open Access
- 15 July 2001
- Vol. 92 (2) , 349-353
- https://doi.org/10.1002/1097-0142(20010715)92:2<349::aid-cncr1329>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mass screening for neuroblastoma at 6 months of age: Difficult to justifyJournal of Pediatric Surgery, 1998
- Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in JapanJournal of Pediatric Surgery, 1996
- One hundred neuroblastomas detected through a mass screening system in JapanCancer, 1994
- Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smearsBritish Journal of Cancer, 1994
- Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older childrenThe Journal of Pediatrics, 1991
- Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10-year retrospective studyCancer, 1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984
- Neuroblastoma. Mass screening for early detection and its prognosisCancer, 1984
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971